Brief: AC Immune Reports Positive Interim Results From Phase 2 Trial Of ACI-7104.056

AC Immune SA

14/11/2024 12:29

Nov 14 (Reuters) - AC Immune SA  ACIU.O :
    * AC IMMUNE REPORTS POSITIVE INTERIM RESULTS FROM PHASE 2
TRIAL OF
ACI-7104.056 ACTIVE IMMUNOTHERAPY IN EARLY PARKINSON’S DISEASE
    * AC IMMUNE SA - ACI-7104.056 WELL TOLERATED WITH NO
CLINICALLY
RELEVANT SAFETY ISSUES
    * AC IMMUNE SA - 100% OF PATIENTS RESPOND TO ACI-7104.056
    * AC IMMUNE SA - MAY INITIATE PART 2 OF VACSYN WITH UP TO
150
PATIENTS

Source text:  urn:newsml:reuters.com:*:nGNX9sbKKq
Further company coverage:  ACIU.O 

 ((Reuters.Briefs@thomsonreuters.com;))